GlassScriptPhysician profile
Jade Cyr
NPI 1255925145
$4,169.12
in general payments reported to CMS, 2019-2025
23 companies · $733 in 2025
The $733 reported for 2025 was more than what 80% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $199 · 2022: $784 · 2023: $1,265 · 2024: $1,189 · 2025: $733.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,186.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $992.11 | 2022-2025 | Barostim Neo System |
| Kestra Medical Technology Services, INC. | $515.17 | 2022-2025 | Assure Wcd |
| Atricure, INC. | $423.72 | 2023-2025 | Synergy Ablation System, Epi-Ease Epicardial Access System, Atriclip Laa Exclusion System |
| Medtronic, INC. | $368.37 | 2021-2024 | Harmony, Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Impulse Dynamics (USA) INC. | $349.79 | 2022-2025 | Optimizer, Optimizer |
| Amgen INC. | $296.11 | 2021-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $239.16 | 2022-2025 | |
| Alnylam Pharmaceuticals INC. | $176.81 | 2023-2025 | Amvuttra, Onpattro |
| Merck Sharp & Dohme LLC | $142.10 | 2021-2025 | Verquvo |
| Actelion Pharmaceuticals US, INC. | $117.19 | 2025 | Uptravi, Opsumit |
| Boston Scientific Corporation | $77.56 | 2022-2023 | Ekosonic |
| Janssen Pharmaceuticals, INC | $72.77 | 2021-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $70.40 | 2023-2024 | Camzyos, Eliquis |
| Abbott Laboratories | $64.07 | 2022-2025 | Amplatzer Amulet |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $55.84 | 2022-2024 | Lifevest |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $40.18 | 2024-2025 | Nexletol |
| Pfizer INC. | $36.48 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.56 | 2023 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $24.45 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $22.74 | 2023 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $19.48 | 2023 | Inpefa |
| Irhythm Technologies, INC. | $18.91 | 2024 | Zio Xt Patch, Zio Monitor |
| Astrazeneca Pharmaceuticals LP | $17.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jade Cyr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.